| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/09/1998 | WO1998029747A1 Reagents and methods for detecting hepatitis gb virus antigen |
| 07/09/1998 | WO1998029565A2 Novel method for testing the differentiation status in pancreatic cells of a mammal |
| 07/09/1998 | WO1998029551A1 THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1) |
| 07/09/1998 | WO1998029548A1 Human mage-like protein |
| 07/09/1998 | WO1998029543A1 Compounds for modulating cell negative regulations and biological applications thereof |
| 07/09/1998 | WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use |
| 07/09/1998 | WO1998029450A1 Antigenic peptides reacting with anti-ovary antibodies |
| 07/09/1998 | WO1998029445A1 α-AMINO-BUTYRATE DERIVATIVES OF VENOMS |
| 07/09/1998 | WO1998029444A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 07/09/1998 | WO1998029442A1 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES |
| 07/09/1998 | WO1998029134A2 Microporation of tissue for delivery of bioactive agents |
| 07/09/1998 | WO1998029133A1 Pharmaceutical preparation and method for treatment and prevention of fibromyalgia and chronic fatigue |
| 07/09/1998 | WO1998029132A1 Early detection of mycobacterial disease |
| 07/09/1998 | WO1998029121A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/09/1998 | WO1998018818A3 Hepatitis b inhibitors |
| 07/09/1998 | WO1998017796A3 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 07/09/1998 | WO1998008542A3 Compounds and methods for treatment and diagnosis of mycobacterial infections |
| 07/09/1998 | CA2276490A1 Antigenic peptides reacting with anti-ovary antibodies |
| 07/09/1998 | CA2276450A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/09/1998 | CA2276112A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
| 07/09/1998 | CA2275975A1 Human mage-like protein |
| 07/09/1998 | CA2274585A1 Annexin v-binding polypeptides derived from hbsag and their uses |
| 07/08/1998 | EP0851927A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/08/1998 | EP0851924A1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/08/1998 | EP0851923A2 Fmr1-related protein |
| 07/08/1998 | EP0851921A1 Genetic alterations related to familial alzheimer's disease |
| 07/08/1998 | EP0851875A2 Dna sequences and secreted proteins encoded thereby |
| 07/08/1998 | EP0851873A2 Parainfluenza virus glycoproteins and vaccines |
| 07/08/1998 | EP0851872A2 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 07/08/1998 | EP0851869A1 Breast specific genes and proteins |
| 07/08/1998 | EP0851768A2 Interactive molecular conjugates |
| 07/08/1998 | EP0851765A1 Therapeutic and prophylactic methods using heat shock proteins |
| 07/08/1998 | EP0851764A1 Heat shock protein-based vaccines and immunotherapies |
| 07/08/1998 | EP0619841B1 T-cadherin adhesion molecule |
| 07/08/1998 | EP0571538B1 Structural gene of pneumococcal protein |
| 07/08/1998 | EP0528931B1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
| 07/08/1998 | EP0398955B1 Diagnosis of retinoblastoma |
| 07/08/1998 | CN1187217A Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
| 07/08/1998 | CN1187200A An improved peptide immunogenic composition and vaccine or medical preparation. Method to immunise animals against hormons LHRH and alalogs of LHRH tandem repeat peptide |
| 07/08/1998 | CN1187136A Modified meningococcal polysacharide conjugate vaccines |
| 07/08/1998 | CN1186696A Application of beneficial bacteria in improving specific immunity of organism specific and in development of vaccine |
| 07/08/1998 | CN1186695A Recombinant coccidiosis vaccines |
| 07/08/1998 | CN1039015C Polyethylene glycol-interferon conjugates |
| 07/07/1998 | US5777097 Oligonucleotides comprising a region of a cytokine suppressive anti-inflammatory drug binding protein |
| 07/07/1998 | US5777095 Dna and nucleotide sequences |
| 07/07/1998 | US5777083 Stress protein epitopes |
| 07/07/1998 | US5777074 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| 07/07/1998 | US5776968 Therapeutic uses of melanin |
| 07/07/1998 | US5776895 Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock |
| 07/07/1998 | US5776776 DTEF-1 isoforms and uses thereof |
| 07/07/1998 | US5776761 Nucleic acids encoding allergenic proteins from ragweed |
| 07/07/1998 | US5776750 Amino acid sequences and polypeptides for hybridizing and genes |
| 07/07/1998 | US5776746 Efficient isolation of amplified cell lines which express theproteins of interest in a relatively short period of time |
| 07/07/1998 | US5776712 Methods and materials for the detection of Staphylococcus aureus |
| 07/07/1998 | US5776468 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A |
| 07/07/1998 | US5776465 Recombinant mycobacterial vaccines |
| 07/07/1998 | US5776457 Antibodies to human PF4A receptor and compositions thereof |
| 07/07/1998 | US5776456 Administering a polypeptide |
| 07/07/1998 | US5776095 Pretargeting noncanerous cells or tissues with a cytoprotective agents before therapy with radiation or anticarcinogenic agents |
| 07/07/1998 | US5776094 Method and kit for imaging and treating organs and tissues |
| 07/07/1998 | US5776093 Method for imaging and treating organs and tissues |
| 07/07/1998 | CA2031354C Method of stabilizing recombinant hepatitis b virus surface proteins from yeast |
| 07/02/1998 | WO1998028625A1 Method for diagnosis and therapy of hodgkin lymphomas |
| 07/02/1998 | WO1998028621A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | WO1998028445A1 Recombinant n-smases and nucleic acids encoding same |
| 07/02/1998 | WO1998028426A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily |
| 07/02/1998 | WO1998028424A2 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 07/02/1998 | WO1998028423A2 Compositions and methods of use for osteoclast inhibitory factors |
| 07/02/1998 | WO1998028418A1 Tailless nuclear hormone receptor (tlx receptor) |
| 07/02/1998 | WO1998028357A1 Biodegradable targetable microparticle delivery system |
| 07/02/1998 | WO1998028333A2 USPA1 AND USPA2 ANTIGENS OF $i(MORAXELLA CATARRHALIS) |
| 07/02/1998 | WO1998028005A1 Chlamydia vaccines |
| 07/02/1998 | WO1998028004A1 Hepatitis delta particle containing a fusion protein immunogen |
| 07/02/1998 | WO1998028003A1 Formulations of recombinant papillomavirus vaccines |
| 07/02/1998 | WO1998028001A1 Treatment of autoimmune diseases, including aids |
| 07/02/1998 | WO1998028000A1 Stabilizers for lyophilized vaccines |
| 07/02/1998 | WO1998027999A2 Anti-allergenic compounds for the treatment of immune diseases containing haptenized antigen antibody complexes |
| 07/02/1998 | WO1998027966A2 Encapsulated cells producing antibodies |
| 07/02/1998 | WO1998027964A1 Veterinary vaccines |
| 07/02/1998 | WO1998027819A1 dapE GENE OF HELICOBACTER PYLORI AND dapE- MUTANT STRAINS OF $i(HELICOBACTER PYLORI) |
| 07/02/1998 | WO1998027813A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2276149A1 Methods for treating insulin resistance and identifying patients at risk for the disease |
| 07/02/1998 | CA2276090A1 Recombinant n-smases and nucleic acids encoding same |
| 07/02/1998 | CA2275896A1 Chlamydia vaccines |
| 07/02/1998 | CA2275692A1 Treatment of autoimmune diseases |
| 07/02/1998 | CA2274755A1 Stabilizers for lyophilized vaccines |
| 07/02/1998 | CA2274675A1 Vegf-b/receptor complex and uses thereof |
| 07/02/1998 | CA2272855A1 Method of diagnosis and therapy of hodgkin's lymphomas |
| 07/02/1998 | CA2246787A1 Novel compounds |
| 07/02/1998 | CA2219265A1 Human cardiac/brain tolloid-like protein |
| 07/01/1998 | EP0850648A2 Combination of thrombolytically active proteins and anticoagulants and uses thereof |
| 07/01/1998 | EP0850305A2 Compounds and methods for diagnosis of tuberculosis |
| 07/01/1998 | EP0850244A1 Toxoplasma gondii glycoconjugates |
| 07/01/1998 | EP0850071A1 Gene therapy for effector cell regulation |
| 07/01/1998 | EP0850069A1 Method for inducing humoral and cellular immune responses utilizing intracellular delivery of peptide-coated microparticles |
| 07/01/1998 | CN1186518A Human vascular endothelial growth factor 2 |
| 07/01/1998 | CN1186517A Altered polypeptides with increased half-life |
| 07/01/1998 | CN1186515A 转化生长因子αHI Transforming growth factor αHI |
| 07/01/1998 | CN1186500A Monoclonal antibodies against HIV-1 and vaccines made thereof |
| 07/01/1998 | CN1186440A Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |